ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?

• Stefan Garczyk ,

  Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Resources, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: sgarczyk@ukaachen.de

  Affiliation Uropathology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany

  http://orcid.org/0000-0001-5447-3207

  ⨯
• Ursula Schneider,

  Roles Investigation, Methodology

  Affiliation Uropathology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany

  ⨯
• Isabella Lurje,

  Roles Investigation, Writing – review & editing

  Affiliation Uropathology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany

  ⨯
• Katharina Becker,

  Roles Investigation

  Affiliation Uropathology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany

  ⨯
• Thomas A. Vögeli,

  Roles Resources

  Affiliation Department of Urology, University Hospital RWTH Aachen, Aachen, Germany

  ⨯
• Nadine T. Gaisa,

  Roles Investigation, Resources, Writing – review & editing

  Affiliation Uropathology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany

  ⨯
• Ruth Knüchel

  Roles Funding acquisition, Investigation, Resources, Supervision, Writing – review & editing

  Affiliation Uropathology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany

  ⨯